Cargando…
Data-driven strategies for increasing patient diversity in Bristol Myers Squibb–sponsored US oncology clinical trials
BACKGROUND/AIMS: Determining whether clinical trial findings are applicable to diverse, real-world patient populations can be challenging when the full demographic characteristics of enrolled patients are not consistently reported. Here, we present the results of a descriptive analysis of racial and...
Autores principales: | Kuri, Lorena, Setru, Sagar, Liu, Gengyuan, Reed, Diane Moniz, Weigand, David, Surampudi, Aparna, Berger, Susan, Paulucci, David, Rai, Angshu, Sethuraman, Venkat, Vito, Blythe, Kellar-Wood, Helen, Balan, Mariann Micsinai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638849/ https://www.ncbi.nlm.nih.gov/pubmed/37309819 http://dx.doi.org/10.1177/17407745231180506 |
Ejemplares similares
-
eJIAS and the Bristol-Myers Squibb Foundation's Secure the Future Program
por: Damonti, John
Publicado: (2004) -
Squibbs’ Epidermis
Publicado: (1886) -
Dr. Squibb
Publicado: (1882) -
Squibb’s Materia Medica
Publicado: (1908) -
Dr. Edward Robinson Squibb
Publicado: (1900)